Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -40.48 | N/A |
PEG Ratio (TTM) | -8.50 | N/A |
P/S Ratio (TTM) | 5.99 | N/A |
P/B Ratio (TTM) | 16.86 | N/A |
P/FCF Ratio (TTM) | 154.66 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -14.93% | N/A |
ROE (TTM) | -39.41% | N/A |
Net Profit Margin (TTM) | -14.64% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (28%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 3.00% | -14.36% | N/A |
Revenue | 4.74% | 47.44% | N/A |
Net Income | 2.92% | -14.83% | N/A |
Cash Flow | -119.83% | 11.91% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.59 | N/A |
Quick Ratio (TTM) | 1.59 | N/A |
D/E Ratio (TTM) | 0.15 | N/A |
Interest Coverage (TTM) | -20.52 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 4.48 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |